Breakthrough: scientists can target cancer cells with 50 times less chemo
The Paclitaxel chemotherapy drug is used to treat breast cancer, lung and pancreatic cancer by slowing the growth and the division of cancerous cells. But once administered, the drug is attacked by the body's immune system, so it is be necessary to constantly increase the dose, thus creating various complications such as joint pain, diarrhea and a reduced capacity of the organism to defend itself against other infections. Researchers at the...